As of 4:00pm ET
| +0.27 / +3.28%|
The 4 analysts offering 12-month price forecasts for Corcept Therapeutics Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 5.00. The median estimate represents a +5.76% increase from the last price of 8.51.
The current consensus among 4 polled investment analysts is to Buy stock in Corcept Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.